France Steps in to Smooth Sanofi's High-Stakes Deal; UK Calls for NHS Overhaul

The UK health secretary will initiate a national dialogue to address the pressing issues facing the NHS. Meanwhile, France acquires a minor share in Sanofi's consumer healthcare sector to facilitate a €15.5 billion transaction with a US private equity firm.

In an effort to address the long-standing issues plaguing the National Health Service, UK health secretary Wes Streeting is set to initiate a 'national conversation' on Monday. Streeting has referred to the state of the NHS as dire, prompting the need for public input and solutions.

Across the Channel, France is making a strategic move by purchasing a small stake in Sanofi's consumer healthcare business. This step is part of an effort to ease the completion of a politically sensitive deal that values the unit at €15.5 billion and involves a handover to US private equity group Clayton, Dubilier & Rice.

These developments unfold as both nations navigate significant deals and restructuring efforts in their respective domains, highlighting the importance of transnational cooperation and public engagement in shaping the future of healthcare services and business transactions.

(With inputs from agencies.)